FolioLanternBeta
BMYBristol Myers Squibb

Cristian Massacesi

EVP,Chief Med Offr,Head of Dev at Bristol Myers Squibb, as of Sep 10, 2026Sold $403K of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
25%†
share of stake sold at Bristol Myers Squibb
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
19K
shares held after the latest filing, Bristol Myers Squibb
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAugSep 2026: $403K no plan disclosed$403KSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Bristol Myers Squibb (BMY)EVP,Chief Med Offr,Head of DevAug 5, 2025Sep 10, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.